Deriphyllin (Theophylline) Dosing Per Kilogram
For intravenous loading: 4.6 mg/kg theophylline (5.7 mg/kg as aminophylline) over 30 minutes produces an average serum concentration of 10 mcg/mL; for maintenance infusion: 0.4 mg/kg/hr in non-smoking adults or 0.8 mg/kg/hr in children age 1-9 years. 1
Loading Dose Administration
The standard loading dose is 4.6 mg/kg of theophylline (5.7 mg/kg as aminophylline) calculated on ideal body weight, administered intravenously over 30 minutes. 1 This produces a maximum post-distribution serum concentration averaging 10 mcg/mL with a range of 6-16 mcg/mL. 1
Critical Considerations Before Loading:
- Do not give a loading dose if the patient has received any theophylline in the previous 24 hours without first obtaining a serum level. 1
- If prior theophylline use is confirmed, calculate the loading dose as: D = (Desired C - Measured C) × 0.5 L/kg, where desired concentration should be conservative at 10 mcg/mL. 1
- Each mg/kg administered increases serum concentration by approximately 2 mcg/mL on average. 1
Maintenance Infusion Rates
After the loading dose, initiate continuous infusion based on patient population:
Non-Smoking Adults:
- 0.4 mg/kg/hr theophylline (0.5 mg/kg/hr as aminophylline) achieves steady-state of 10 mcg/mL (range 7-26 mcg/mL). 1
Children Age 1-9 Years:
- 0.8 mg/kg/hr theophylline (1.0 mg/kg/hr as aminophylline) achieves similar steady-state concentrations. 1
Elderly Patients (>60 years):
- Reduce dose by 30% as clearance decreases by an average of 30% compared to young adults. 1
Patients with Hepatic Insufficiency or CHF:
- Reduce dose by 50% or more as clearance is decreased by 50% or more in these populations. 1
Smokers:
- May require higher doses as tobacco smoking increases theophylline clearance through metabolic pathway induction. 1
Therapeutic Monitoring Algorithm
Obtain serum theophylline concentration 30 minutes after loading dose completion to assess need for additional loading and guide continuing therapy. 1
Obtain second serum concentration one expected half-life after starting constant infusion:
Target therapeutic range: 5-15 mcg/mL for optimal bronchodilation with minimal side effects. 2 The European Respiratory Society recommends adjusting doses to achieve peak serum levels of 5-15 μg/L. 2
Clinical Context and Positioning
Theophyllines should only be tried in severe COPD patients who remain symptomatic despite combination β2-agonist and anticholinergic bronchodilators, and must be monitored closely for side effects. 2 The British Thoracic Society guidelines emphasize that oral bronchodilators are not usually required in moderate disease. 2
Important Caveats:
- Wide interpatient variability exists in theophylline clearance, causing fourfold differences in dose requirements among similar patients. 1
- Nonlinear elimination may begin at concentrations <10 mcg/mL in some patients, requiring small incremental dose adjustments. 1
- Neonates require special attention: approximately 50% is excreted unchanged in urine (versus 10% in older children/adults), necessitating careful dose reduction and frequent monitoring. 1
- No renal dose adjustment needed in adults and children >3 months of age, as only 10% is excreted unchanged. 1